Bazemore Robert B
SEC insider (Form 3/4/5 filer). CIK 0001620152. Director at Akari Therapeutics Plc (AKTX) and 2 other issuers. 17 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in TAMPA, FL.
Companies Bazemore Robert B has filed insider reports for
- Akari Therapeutics Plc (AKTX): Director
- ARDELYX, INC. (ARDX): Director
- Nuvation Bio Inc. (NUVB): Director
Bazemore Robert B
CIK: 0001620152
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Oct 14, 2026AKTX
Akari Therapeutics Plc
ExerciseDirect773 shares at avg. $0.00$0.309 - Oct 14, 2026AKTX
Akari Therapeutics Plc
ExerciseDirect3.1K shares at avg. $0.00$1.237 - Oct 5, 2026AKTX
Akari Therapeutics Plc
AwardDirect4.7K shares at avg. $7.90$37K - Aug 18, 2026AKTX
Akari Therapeutics Plc
AwardDirect13.1K shares at avg. $7.90$103K - Jun 16, 2026ARDX
ARDELYX, INC.
AwardDirect26.5K shares- - May 21, 2026NUVB
Nuvation Bio Inc.
AwardDirectStock Option (Right to Buy)
123.4K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
123.7K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase American Depositary Shares ("ADRs")
123.7K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase ADRs
30.9K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
30.9K shares at avg. $0.40-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 14, 2026 |  AKTX Akari Therapeutics Plc | Exercise | 773 | $0.00 | $0 | Direct |
| Oct 14, 2026 | AKTX Akari Therapeutics Plc | Exercise | 3,093 | $0.00 | $1 | Direct |
| Oct 5, 2026 | AKTX Akari Therapeutics Plc | Award | 4,677 | $7.90 | $36,944 | Direct |
| Aug 18, 2026 | AKTX Akari Therapeutics Plc | Award | 13,100 | $7.90 | $103,477 | Direct |
| Jun 16, 2026 |  ARDX ARDELYX, INC. | Award | 26,455 | - | $0 | Direct |
| May 21, 2026 |  NUVB Nuvation Bio Inc. | Award Stock Option (Right to Buy) | 123,397 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 123,731 | $0.40 | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase American Depositary Shares ("ADRs") | 123,731 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase ADRs | 30,932 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 30,932 | $0.40 | - | Direct |
1-10 of 17 transactions